Platelets in wound healing and regenerative medicine

References

• Rittie L. Cellular mechanisms of skin repair in humans and other mammals. J Cell Commun Signal. 2016;10(2):103–120. doi:10.1007/s12079-016-0330-1.
   PubMed Web of Science ®Google Scholar
• Xue M, Jackson CJ. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care (New Rochelle). 2015;4(3):119–136. doi:10.1089/wound.2013.0485.
   PubMed Web of Science ®Google Scholar
• Wu B, Mottola G, Schaller M, Upchurch GR Jr., Conte MS. Resolution of vascular injury: specialized lipid mediators and their evolving therapeutic implications. Mol Aspects Med. 2017;58:72–82. doi:10.1016/j.mam.2017.07.005.
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Rosenthal N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med. 2014;20(8):857–869. doi:10.1038/nm.3653.
   PubMed Web of Science ®Google Scholar
• Paul W, Sharma CP. Advances in wound healing materials: science and skin engineering. Vol. 1. Shawbury, Shrewsbury, Shropshire, UK: Smithers Rapra Technology; 2016.
   Google Scholar
• Briquez PS, Hubbell JA, Martino MM. Extracellular matrix-inspired growth factor delivery systems for skin wound healing. Adv Wound Care (New Rochelle). 2015;4(8):479–489. doi:10.1089/wound.2014.0603.
   PubMed Web of Science ®Google Scholar
• Powers JG, Higham C, Broussard K, Phillips TJ. Wound healing and treating wounds: chronic wound care and management. J Am Acad Dermatol. 2016;74(4):607–625. doi:10.1016/j.jaad.2015.08.070.
   PubMed Web of Science ®Google Scholar
• Ackermann PW, Hart DA. Influence of comorbidities: neuropathy, vasculopathy, and diabetes on healing response quality. Adv Wound Care (New Rochelle). 2013;2(8):410–421. doi:10.1089/wound.2012.0437.
   PubMedGoogle Scholar
• Burnouf T, Strunk D, Koh MB, Schallmoser K. Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials. 2016;76:371–387. doi:10.1016/j.biomaterials.2015.10.065.
   PubMed Web of Science ®Google Scholar
• De Pascale MR, Sommese L, Casamassimi A, Napoli C. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev. 2015;29(1):52–61. doi:10.1016/j.tmrv.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Alsousou J, Harrison P. Platelet-rich plasma in regenerative medicine. In: Gresele P, López JA, Kleiman NS, et al. editors. Platelets in thrombotic and non-thrombotic disorders. Switzerland: Springer; 2017.
   Google Scholar
• Nurden AT. The biology of the platelet with special reference to inflammation, wound healing and immunity. Front Biosci (Landmark Ed). 2018;23:726–751. doi:10.2741/4613.
   PubMed Web of Science ®Google Scholar
• Etulain J, Negrotto S, Schattner M. Role of platelets in angiogenesis in health and disease. Curr Angiogenesis. 2014;3(1):1–10. doi:10.2174/2211552802666140404002756.
   Google Scholar
• Anitua E, Prado R, Sanchez M, Orive G. Platelet-rich plasma: preparation and formulation. Oper Tech Orthop. 2012;22(1):25–32. doi:10.1053/j.oto.2012.01.004.
   Google Scholar
• Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24(3):173–182. doi:10.3109/09537104.2012.684730.
   PubMed Web of Science ®Google Scholar
• Jung S, Panchalingam KM, Rosenberg L, Behie LA. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int. 2012;2012:123030. doi:10.1155/2012/123030.
   PubMed Web of Science ®Google Scholar
• Dietz AB, Padley DJ, Gastineau DA. Infrastructure development for human cell therapy translation. Clin Pharmacol Ther. 2007;82(3):320–324. doi:10.1038/sj.clpt.6100288.
   PubMed Web of Science ®Google Scholar
• Von Tigerstrom B. Product regulation and the clinical translation of stem cell research. Stem Cell Rev. 2009;5(2):135–139. doi:10.1007/s12015-009-9059-z.
   PubMed Web of Science ®Google Scholar
• Etulain J, Mena HA, Negrotto S, Schattner M. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets. Platelets. 2015;26(8):799–804. doi:10.3109/09537104.2015.1051953.
   PubMed Web of Science ®Google Scholar
• Amable PR, Carias RB, Teixeira MV, Da Cruz Pacheco I, Correa Do Amaral RJ, Granjeiro JM, Borojevic R. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. doi:10.1186/scrt218.
   PubMed Web of Science ®Google Scholar
• Peterson JE, Zurakowski D, Italiano JE Jr., Michel LV, Fox L, Klement GL, Folkman J. Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol. 2010;85(7):487–493. doi:10.1002/ajh.v85:7.
   PubMed Web of Science ®Google Scholar
• Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 2005;65(10):3967–3979. doi:10.1158/0008-5472.CAN-04-2427.
   PubMed Web of Science ®Google Scholar
• Fabbro MD, Bortolin M, Taschieri S, Ceci C, Weinstein RL. Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence. Platelets. 2016;27(4):276–285. doi:10.3109/09537104.2015.1116686.
   PubMed Web of Science ®Google Scholar
• Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol. 2014;12(6):426–437. doi:10.1038/nrmicro3269.
   PubMed Web of Science ®Google Scholar
• Liggett PE, Skolik DS, Horio B, Saito Y, Alfaro V, Mieler W. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology. 1995;102(7):1071–1076.
   PubMed Web of Science ®Google Scholar
• Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529–535.
   PubMed Web of Science ®Google Scholar
• Oryan A, Alidadi S, Moshiri A. Platelet-rich plasma for bone healing and regeneration. Expert Opin Biol Ther. 2016;16(2):213–232. doi:10.1517/14712598.2016.1118458.
   PubMed Web of Science ®Google Scholar
• Kreuz PC, Kruger JP, Metzlaff S, Freymann U, Endres M, Pruss A, Petersen W, Kaps C. Platelet-rich plasma preparation types show impact on chondrogenic differentiation, migration, and proliferation of human subchondral mesenchymal progenitor cells. Arthroscopy. 2015;31(10):1951–1961. doi:10.1016/j.arthro.2015.03.033.
   PubMed Web of Science ®Google Scholar
• Kim TH, Kim SH, Sandor GK, Kim YD. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol. 2014;59(5):550–558. doi:10.1016/j.archoralbio.2014.02.004.
   PubMed Web of Science ®Google Scholar
• Lin BN, Whu SW, Chen CH, Hsu FY, Chen JC, Liu HW, Liou HM. Bone marrow mesenchymal stem cells, platelet-rich plasma and nanohydroxyapatite-type I collagen beads were integral parts of biomimetic bone substitutes for bone regeneration. J Tissue Eng Regen Med. 2013;7(11):841–854. doi:10.1002/term.1472.
   PubMed Web of Science ®Google Scholar
• Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A, Nagae M, Arai Y, Kawata M, Kubo T. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol. 2008;215(3):837–845. doi:10.1002/(ISSN)1097-4652.
   PubMed Web of Science ®Google Scholar
• Bertoldi C, Pinti M, Zaffe D, Cossarizza A, Consolo U, Ceccherelli GB. Morphologic, histochemical, and functional analysis of platelet-rich plasma activity on skeletal cultured cells. Transfusion. 2009;49(8):1728–1737. doi:10.1111/trf.2009.49.issue-8.
   PubMed Web of Science ®Google Scholar
• Akeda K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ, Lenz ME, Sah RL, Masuda K. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006;14(12):1272–1280. doi:10.1016/j.joca.2006.05.008.
   PubMed Web of Science ®Google Scholar
• Lyras D, Kazakos K, Verettas D, Polychronidis A, Simopoulos C, Botaitis S, Agrogiannis G, Kokka A, Patsouris E. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop. 2010;34(1):143–148. doi:10.1007/s00264-009-0728-y.
   PubMed Web of Science ®Google Scholar
• Pantou AL, Markopoulou CE, Dereka XE, Vavouraki H, Mamalis A, Vrotsos IA. The effect of platelet-rich plasma (PRP) combined with a bone allograft on human periodontal ligament (PDL) cells. Cell Tissue Bank. 2012;13(1):81–88. doi:10.1007/s10561-010-9231-3.
   PubMed Web of Science ®Google Scholar
• Feng Y, Sun Y, Jia W, Zhang C. Platelet-rich plasma and 1,25(OH)2 vitamin D3 synergistically stimulate osteogenic differentiation of adult human mesenchymal stem cells. Biotechnol Lett. 2010;32(5):635–642. doi:10.1007/s10529-009-0198-8.
   PubMed Web of Science ®Google Scholar
• Huang S, Wang Z. Influence of platelet-rich plasma on proliferation and osteogenic differentiation of skeletal muscle satellite cells: an in vitro study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(4):453–462. doi:10.1016/j.tripleo.2010.02.009.
   PubMed Web of Science ®Google Scholar
• Shin MK, Lee JW, Kim YI, Kim Y-O, Seok H, Kim NI. The effects of platelet-rich clot releasate on the expression of MMP-1 and type I collagen in human adult dermal fibroblasts: PRP is a stronger MMP-1 stimulator. Mol Biol Rep. 2014;41(1):3–8. doi:10.1007/s11033-013-2718-9.
   PubMed Web of Science ®Google Scholar
• Guszczyn T, Surazynski A, Zareba I, Rysiak E, Popko J, Palka J. Differential effect of platelet-rich plasma fractions on beta1-integrin signaling, collagen biosynthesis, and prolidase activity in human skin fibroblasts. Drug Des Devel Ther. 2017;11:1849–1857. doi:10.2147/DDDT.S135949.
   PubMed Web of Science ®Google Scholar
• Anitua E, Pino A, Orive G. Plasma rich in growth factors promotes dermal fibroblast proliferation, migration and biosynthetic activity. J Wound Care. 2016;25(11):680–687. doi:10.12968/jowc.2016.25.11.680.
   PubMed Web of Science ®Google Scholar
• Takikawa M, Nakamura S, Nambu M, Ishihara M, Fujita M, Kishimoto S, Doumoto T, Yanagibayashi S, Azuma R, Yamamoto N, others. Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles. J Biomed Mater Res B Appl Biomater. 2011;97(2):373–380. doi:10.1002/jbm.b.31824.
   PubMed Web of Science ®Google Scholar
• Xiao S-E, Miao Y, Wang J, Jiang W, Fan Z-X, Liu X-M, Hu Z-Q. As a carrier-transporter for hair follicle reconstitution, platelet-rich plasma promotes proliferation and induction of mouse dermal papilla cells. Sci Rep. 2017;7(1):1125. doi:10.1038/s41598-017-01105-8.
   PubMedGoogle Scholar
• Anitua E, Sanchez M, Merayo-Lloves J, De La Fuente M, Muruzabal F, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. Invest Ophthalmol Vis Sci. 2011;52(9):6066–6073. doi:10.1167/iovs.11-7302.
   PubMed Web of Science ®Google Scholar
• Mammoto T, Jiang A, Jiang E, Mammoto A. Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway. Microvasc Res. 2013;89:15–24. doi:10.1016/j.mvr.2013.04.008.
   PubMed Web of Science ®Google Scholar
• De Pascale MR, Lanza M, Sommese L, Napoli C. Human serum eye drops in eye alterations: an insight and a critical analysis. J Ophthalmol. 2015;2015:396410.
   PubMedGoogle Scholar
• Society. TICM. Guidelines for the use of platelet rich plasma. In Best Practices Standards in Cell Based Med. 2012.
   Google Scholar
• WHO. Guidelines on good manufacturing practices for blood establishments. World Health Organ Tech Rep Ser. 2011;961(Annex4):148–214.
   Google Scholar
• HealthCare EDftQoM. Guide to the preparation, use and quality assurance of blood components. Strasbourg: 15 RNR, editor; 2015.
   Google Scholar
• Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: A review and author′s perspective. J Cutan Aesthet Surg. 2014;7(4):189–197. doi:10.4103/0974-2077.150734.
   PubMedGoogle Scholar
• Henriksen PA. The potential of neutrophil elastase inhibitors as anti-inflammatory therapies. Curr Opin Hematol. 2014;21(1):23–28. doi:10.1097/MOH.0000000000000001.
   PubMed Web of Science ®Google Scholar
• Anitua E, Zalduendo M, Troya M, Padilla S, Orive G. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One. 2015;10(3):e0121713. doi:10.1371/journal.pone.0121713.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yin W, Zhang Y, Qi X, Chen Y, Xie X, Zhang C. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration. Sci Rep. 2017;7:43301. doi:10.1038/srep43301.
   PubMed Web of Science ®Google Scholar
• D’Asta F, Halstead F, Harrison P, Zecchi Orlandini S, Moiemen N, Lord J. The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: a systematic review. Platelets. 2017:1–12. doi:10.1080/09537104.2017.1317731.
   Web of Science ®Google Scholar
• Uccioli L, Izzo V, Meloni M, Vainieri E, Ruotolo V, Giurato L. Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings. J Wound Care. 2015;24(4 Suppl):35–42. doi:10.12968/jowc.2015.24.Sup4b.35.
   PubMed Web of Science ®Google Scholar
• Degen RM, Bernard JA, Oliver KS, Dines JS. Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition. Hss J. 2017;13(1):75–80. doi:10.1007/s11420-016-9519-3.
   PubMedGoogle Scholar
• Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014;42(5):1204–1210. doi:10.1177/0363546514525593.
   PubMed Web of Science ®Google Scholar
• Milants C, Bruyère O, Kaux J-F. Responders to platelet-rich plasma in osteoarthritis: a technical analysis. Biomed Res Int. 2017;2017:1–11. doi:10.1155/2017/7538604.
   Google Scholar
• Dhillon MS, Patel S, John R. PRP in OA knee - update, current confusions and future options. Sicot J. 2017;3:27. doi:10.1051/sicotj/2017004.
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–167. doi:10.1016/j.tibtech.2008.11.009.
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Bielecki T, Mishra A, Borzini P, Inchingolo F, Sammartino G, Rasmusson L, Everts PA. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol. 2012;13(7):1131–1137. doi:10.2174/138920112800624328.
   PubMed Web of Science ®Google Scholar
• Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185–1195. doi:10.2174/138920112800624283.
   PubMed Web of Science ®Google Scholar
• Ho CH, Chan IH. The influence of time of storage, temperature of storage, platelet number in platelet-rich plasma, packed cell, mean platelet volume, hemoglobin concentration, age, and sex on platelet aggregation test. Ann Hematol. 1995;71(3):129–133. doi:10.1007/BF01702648.
   PubMed Web of Science ®Google Scholar
• Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T, Nelson E. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion. 2006;46(5):835–840. doi:10.1111/trf.2006.46.issue-5.
   PubMed Web of Science ®Google Scholar
• Lee DH, Blajchman MA. Novel treatment modalities: new platelet preparations and substitutes. Br J Haematol. 2001;114(3):496–505. doi:10.1046/j.1365-2141.2001.03004.x.
   PubMed Web of Science ®Google Scholar
• Li J, Chen M, Wei X, Hao Y, Wang J. Evaluation of 3D-printed polycaprolactone scaffolds coated with freeze-dried platelet-rich plasma for bone regeneration. Materials (Basel). 2017;10(7):831. doi:10.3390/ma10070831.
   Web of Science ®Google Scholar
• Shiga Y, Kubota G, Orita S, Inage K, Kamoda H, Yamashita M, Iseki T, Ito M, Yamauchi K, Eguchi Y, others. Freeze-dried human platelet-rich plasma retains activation and growth factor expression after an eight-week preservation period. Asian Spine J. 2017;11(3):329–336. doi:10.4184/asj.2017.11.3.329.
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–646. doi:10.1016/S1079-2104(98)90029-4.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Jackson SP. Platelet factor XIII and calpain negatively regulate integrin alphaIIbbeta3 adhesive function and thrombus Growth. J Biol Chem. 2004;279(29):30697–30706. doi:10.1074/jbc.M403559200.
   PubMed Web of Science ®Google Scholar
• Anitua E, Prado R, Troya M, Zalduendo M, De La Fuente M, Pino A, Muruzabal F, Orive G. Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: anticoagulant removal and reduction in activator concentration. Platelets. 2016;27(5):459–466. doi:10.3109/09537104.2016.1143921.
   PubMed Web of Science ®Google Scholar
• Marlovits S, Mousavi M, Gabler C, Erdos J, Vecsei V. A new simplified technique for producing platelet-rich plasma: a short technical note. Eur Spine J. 2004;13(Suppl 1):S102–106. doi:10.1007/s00586-004-0715-3.
   PubMedGoogle Scholar
• Rodgers GM. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature. J Pediatr Hematol Oncol. 2011;33(2):86–88. doi:10.1097/MPH.0b013e3181ff0e43.
   PubMed Web of Science ®Google Scholar
• Su CY, Chiang CC, Lai WF, Lin KW, Burnouf T. Platelet-derived growth factor-AB and transforming growth factor-beta 1 in platelet gels activated by single-donor human thrombin. Transfusion. 2004;44(6):945. doi:10.1111/j.1537-2995.2004.00382.x.
   PubMed Web of Science ®Google Scholar
• Paterson KL, Nicholls M, Bennell KL, Bates D. Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord. 2016;17:67. doi:10.1186/s12891-016-0920-3.
   PubMed Web of Science ®Google Scholar
• Harrison S, Vavken P, Kevy S, Jacobson M, Zurakowski D, Murray MM. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med. 2011;39(4):729–734. doi:10.1177/0363546511401576.
   PubMed Web of Science ®Google Scholar
• Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e56–60. doi:10.1016/j.tripleo.2005.07.011.
   PubMed Web of Science ®Google Scholar
• Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 1998;125(9):1591–1598.
   PubMed Web of Science ®Google Scholar
• Shah P, Keppler L, Rutkowski J. A review of platelet derived growth factor playing pivotal role in bone regeneration. J Oral Implantol. 2014;40(3):330–340. doi:10.1563/AAID-JOI-D-11-00173.
   PubMed Web of Science ®Google Scholar
• Graham S, Leonidou A, Lester M, Heliotis M, Mantalaris A, Tsiridis E. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs. 2009;18(11):1633–1654. doi:10.1517/13543780903241607.
   PubMed Web of Science ®Google Scholar
• Maddaluno L, Urwyler C, Werner S. Fibroblast growth factors: key players in regeneration and tissue repair. Development. 2017;144(22):4047–4060. doi:10.1242/dev.152587.
   PubMed Web of Science ®Google Scholar
• Kofler N, Simons M. The expanding role of neuropilin: regulation of transforming growth factor-beta and platelet-derived growth factor signaling in the vasculature. Curr Opin Hematol. 2016;23(3):260–267. doi:10.1097/MOH.0000000000000233.
   PubMed Web of Science ®Google Scholar
• Lamora A, Talbot J, Mullard M, Brounais-Le Royer B, Redini F, Verrecchia F. TGF-β signaling in bone remodeling and osteosarcoma progression. Journal of Clinical Medicine. 2016;5(11):96. doi:10.3390/jcm5110096.
   PubMed Web of Science ®Google Scholar
• Fujio K, Komai T, Inoue M, Morita K, Okamura T, Yamamoto K. Revisiting the regulatory roles of the TGF-beta family of cytokines. Autoimmun Rev. 2016;15(9):917–922. doi:10.1016/j.autrev.2016.07.007.
   PubMed Web of Science ®Google Scholar
• Ramirez H, Patel SB, Pastar I. The role of TGFbeta signaling in wound epithelialization. Adv Wound Care (New Rochelle). 2014;3(7):482–491. doi:10.1089/wound.2013.0466.
   PubMedGoogle Scholar
• Gillery P, Leperre A, Maquart FX, Borel JP. Insulin-like growth factor-I (IGF-I) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J Cell Physiol. 1992;152(2):389–396. doi:10.1002/jcp.1041520221.
   PubMed Web of Science ®Google Scholar
• Reckenbeil J, Kraus D, Stark H, Rath-Deschner B, Jager A, Wenghoefer M, Winter J, Gotz W. Insulin-like growth factor 1 (IGF1) affects proliferation and differentiation and wound healing processes in an inflammatory environment with p38 controlling early osteoblast differentiation in periodontal ligament cells. Arch Oral Biol. 2017;73:142–150. doi:10.1016/j.archoralbio.2016.10.010.
   PubMed Web of Science ®Google Scholar
• Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets. 2015;15(2):135–144. doi:10.2174/1871530315666150316121956.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016;15(6):385–403. doi:10.1038/nrd.2015.17.
   PubMed Web of Science ®Google Scholar
• Makki N, Thiel KW, Miller FJ Jr. The epidermal growth factor receptor and its ligands in cardiovascular disease. Int J Mol Sci. 2013;14(10):20597–20613. doi:10.3390/ijms141020597.
   PubMed Web of Science ®Google Scholar
• Wei J, Besner GE. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis. J Surg Res. 2015;197(1):126–138. doi:10.1016/j.jss.2015.03.023.
   PubMed Web of Science ®Google Scholar
• Nanba D, Toki F, Barrandon Y, Higashiyama S. Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation. J Dermatol Sci. 2013;72(2):81–86. doi:10.1016/j.jdermsci.2013.05.009.
   PubMed Web of Science ®Google Scholar
• Koh GY. Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med. 2013;19(1):31–39. doi:10.1016/j.molmed.2012.10.010.
   PubMed Web of Science ®Google Scholar
• Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73.
   PubMed Web of Science ®Google Scholar
• Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, Bigalke B, Mueller I, Schumm M, Schaefer I, others. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation. 2008;117(2):206–215. doi:10.1161/CIRCULATIONAHA.107.714691.
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhang B, Kuang D, Song G. Role of stromal-derived Factor-1 in mesenchymal stem cell paracrine-mediated tissue repair. Curr Stem Cell Res Ther. 2016;11(7):585–592. doi:10.2174/1574888X11666160614102629.
   PubMed Web of Science ®Google Scholar
• Karin N. The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J Leukoc Biol. 2010;88(3):463–473. doi:10.1189/jlb.0909602.
   PubMed Web of Science ®Google Scholar
• Reinders ME, Sho M, Robertson SW, Geehan CS, Briscoe DM. Proangiogenic function of CD40 ligand-CD40 interactions. J Immunol. 2003;171(3):1534–1541. doi:10.4049/jimmunol.171.3.1534.
   PubMed Web of Science ®Google Scholar
• Aloui C, Prigent A, Sut C, Tariket S, Hamzeh-Cognasse H, Pozzetto B, Richard Y, Cognasse F, Laradi S, Garraud O. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. Int J Mol Sci. 2014;15(12):22342–22364. doi:10.3390/ijms151222342.
   PubMed Web of Science ®Google Scholar
• Vandercappellen J, Van Damme J, Struyf S. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. Cytokine Growth Factor Rev. 2011;22(1):1–18. doi:10.1016/j.cytogfr.2010.10.011.
   PubMed Web of Science ®Google Scholar
• McMorran BJ, Wieczorski L, Drysdale KE, Chan J-A, Huang HM, Smith C, Mitiku C, Beeson JG, Burgio G, Foote SJ. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science. 2012;338(6112):1348–1351. doi:10.1126/science.1228892.
   PubMed Web of Science ®Google Scholar
• Varghese MP, Manuel S, Kumar LKS. Potential for osseous regeneration of platelet-rich fibrin-a comparative study in mandibular third molar impaction sockets. J Oral Maxillofac Surg. 2017;75(7):1322–1329. doi:10.1016/j.joms.2017.01.035.
   PubMed Web of Science ®Google Scholar
• Forni F, Marzagalli M, Tesei P, Grassi A. Platelet gel: applications in dental regenerative surgery. Blood Transfus. 2013;11(1):102–107.
   PubMed Web of Science ®Google Scholar
• Nagaveni NB, Praveen RB, Umashankar KV, Pranav B, Sreedevi R, Radhika NB. Efficacy of platelet-rich-plasma (PRP) in bone regeneration after cyst enucleation in pediatric patients–a clinical study. J Clin Pediatr Dent. 2010;35(1):81–87. doi:10.17796/jcpd.35.1.q69168v5268234k9.
   PubMed Web of Science ®Google Scholar
• Kaul RP, Godhi SS, Singh A. Autologous platelet rich plasma after third molar surgery: a comparative study. J Maxillofac Oral Surg. 2012;11(2):200–205. doi:10.1007/s12663-011-0311-0.
   PubMedGoogle Scholar
• Scala M, Gipponi M, Mereu P, Strada P, Corvo R, Muraglia A, Massa M, Bertoglio S, Santi P, Cafiero F. Regeneration of mandibular osteoradionecrosis defect with platelet rich plasma gel. In Vivo. 2010;24(6):889–893.
   PubMed Web of Science ®Google Scholar
• Oncu E, Alaaddinoglu EE. The effect of platelet-rich fibrin on implant stability. Int J Oral Maxillofac Implants. 2015;30(3):578–582. doi:10.11607/jomi.3897.
   PubMed Web of Science ®Google Scholar
• Ogata Y, Bui M, Griffin TJ, Hur Y. Use of allograft with platelet concentrate in the treatment of multiple miller class III gingival recession defects: report of three cases. Int J Periodontics Restorative Dent. 2017;37(3):339–344. doi:10.11607/prd.2673.
   PubMed Web of Science ®Google Scholar
• Anitua E, Murias-Freijo A, Alkhraisat MH, Orive G. Clinical, radiographical, and histological outcomes of plasma rich in growth factors in extraction socket: a randomized controlled clinical trial. Clin Oral Investig. 2015;19(3):589–600. doi:10.1007/s00784-014-1278-2.
   PubMed Web of Science ®Google Scholar
• ArRejaie A, Al-Harbi F, Alagl AS, Hassan KS. Platelet-rich plasma gel combined with bovine-derived xenograft for the treatment of dehiscence around immediately placed conventionally loaded dental implants in humans: cone beam computed tomography and three-dimensional image evaluation. Int J Oral Maxillofac Implants. 2016;31(2):431–438. doi:10.11607/jomi.3859.
   PubMed Web of Science ®Google Scholar
• Badr M, Oliver R, Pemberton P, Coulthard P. Platelet-rich plasma in grafted maxillae: growth factor quantification and dynamic histomorphometric evaluation. Implant Dent. 2016;25(4):492–498. doi:10.1097/ID.0000000000000410.
   PubMed Web of Science ®Google Scholar
• Marenzi G, Riccitiello F, Tia M, Di Lauro A, Sammartino G. Influence of leukocyte- and platelet-rich fibrin (l-PRF) in the healing of simple postextraction sockets: a split-mouth study. Biomed Res Int. 2015;2015:1–6. doi:10.1155/2015/369273.
   Google Scholar
• Tabrizi R, Karagah T, Shahidi S, Zare N. Does platelet-rich plasma enhance healing in the idiopathic bone cavity? A single-blind randomized clinical trial. Int J Oral Maxillofac Surg. 2015;44(9):1175–1180. doi:10.1016/j.ijom.2015.05.011.
   PubMed Web of Science ®Google Scholar
• Bajaj P, Pradeep AR, Agarwal E, Rao NS, Naik SB, Priyanka N, Kalra N. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial. J Periodontal Res. 2013;48(5):573–581. doi:10.1111/jre.2013.48.issue-5.
   PubMed Web of Science ®Google Scholar
• Daif ET. Effect of autologous platelet-rich plasma on bone regeneration in mandibular fractures. Dent Traumatol. 2013;29(5):399–403. doi:10.1111/edt.2013.29.issue-5.
   PubMed Web of Science ®Google Scholar
• Jadhav G, Shah N, Logani A. Revascularization with and without platelet-rich plasma in nonvital, immature, anterior teeth: a pilot clinical study. J Endod. 2012;38(12):1581–1587. doi:10.1016/j.joen.2012.09.010.
   PubMed Web of Science ®Google Scholar
• NCT00856934 CgiNn. 2009 Effect of platelet rich plasma and keratinocyte suspensions on wound healing. https://clinicaltrials.gov/ct2/show/NCT00856934.
   Google Scholar
• Tzeng YS, Deng SC, Wang CH, Tsai JC, Chen TM, Burnouf T. Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series. Biomed Res Int. 2013;2013:837620. doi:10.1155/2013/837620.
   PubMed Web of Science ®Google Scholar
• Giuggioli D, Colaci M, Manfredi A, Mariano M, Ferri C. Platelet gel in the treatment of severe scleroderma skin ulcers. Rheumatol Int. 2012;32(9):2929–2932. doi:10.1007/s00296-011-2038-0.
   PubMed Web of Science ®Google Scholar
• Suthar M, Gupta S, Bukhari S, Ponemone V. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. J Biomed Sci. 2017;24(1):16. doi:10.1186/s12929-017-0324-1.
   PubMed Web of Science ®Google Scholar
• Chignon-Sicard B, Georgiou CA, Fontas E, David S, Dumas P, Ihrai T, Lebreton E. Efficacy of leukocyte- and platelet-rich fibrin in wound healing: a randomized controlled clinical trial. Plast Reconstr Surg. 2012;130(6):819e–829e. doi:10.1097/PRS.0b013e31826d1711.
   PubMed Web of Science ®Google Scholar
• Sclafani AP, McCormick SA. Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix. Arch Facial Plast Surg. 2012;14(2):132–136. doi:10.1001/archfacial.2011.784.
   PubMedGoogle Scholar
• Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg. 2017;38:206–211. doi:10.1016/j.avsg.2016.04.023.
   PubMed Web of Science ®Google Scholar
• Raposio E, Bertozzi N, Bonomini S, Bernuzzi G, Formentini A, Grignaffini E, Pio Grieco M. Adipose-derived stem cells added to platelet-rich plasma for chronic skin ulcer therapy. Wounds. 2016;28(4):126–131.
   PubMed Web of Science ®Google Scholar
• Li L, Chen D, Wang C, Yuan N, Wang Y, He L, Yang Y, Chen L, Liu G. Li X and others. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial. Wound Repair Regen. 2015;23(4):495–505. doi:10.1111/wrr.12294.
   PubMed Web of Science ®Google Scholar
• NCT01600326 CgI. 2017A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection. https://clinicaltrials.gov/ct2/show/NCT01600326.
   Google Scholar
• Zou J, Mo X, Shi Z, Li T, Xue J, Mei G, Li X. A prospective study of platelet-rich plasma as biological augmentation for acute Achilles tendon rupture repair. Biomed Res Int. 2016;2016:1–8. doi:10.1155/2016/9364170.
   Web of Science ®Google Scholar
• Aggarwal AK, Shashikanth VS, Marwaha N. Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study. Int Orthop. 2014;38(2):387–395. doi:10.1007/s00264-013-2136-6.
   PubMed Web of Science ®Google Scholar
• Serra R, Buffone G, Dominijanni A, Molinari V, Montemurro R, De Franciscis S. Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients. Int Wound J. 2013;10(5):612–615. doi:10.1111/iwj.12052.
   PubMed Web of Science ®Google Scholar
• Napolitano M, Matera S, Bossio M, Crescibene A, Costabile E, Almolla J, Almolla H, Togo F, Giannuzzi C, Guido G. Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus. 2012;10(1):72–77.
   PubMed Web of Science ®Google Scholar
• Cervellin M, De Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc. 2012;20(1):114–120. doi:10.1007/s00167-011-1570-5.
   PubMed Web of Science ®Google Scholar
• Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45(2):339–346. doi:10.1177/0363546516665809.
   PubMed Web of Science ®Google Scholar
• Duif C, Vogel T, Topcuoglu F, Spyrou G, Von Schulze Pellengahr C, Lahner M. Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial. Arch Orthop Trauma Surg. 2015;135(7):971–977. doi:10.1007/s00402-015-2227-5.
   PubMed Web of Science ®Google Scholar
• Rha D-W, Park G-Y, Kim Y-K, Kim MT, Lee SC. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013;27(2):113–122. doi:10.1177/0269215512448388.
   PubMed Web of Science ®Google Scholar
• Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, Tschon M, Giavaresi G. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med. 2016;44(3):664–671. doi:10.1177/0363546515620383.
   PubMed Web of Science ®Google Scholar
• Simental-Mendia M, Vilchez-Cavazos JF, Pena-Martinez VM, Said-Fernandez S, Lara-Arias J, Martinez-Rodriguez HG. Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136(12):1723–1732. doi:10.1007/s00402-016-2545-2.
   PubMed Web of Science ®Google Scholar
• Montanez-Heredia E, Irizar S, Huertas PJ, Otero E, Del Valle M, Prat I, Diaz-Gallardo MS, Peran M, Marchal JA, Hernandez-Lamas Mdel C. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish National Health Care System. Int J Mol Sci. 2016;17(7). doi:10.3390/ijms17071064.
   PubMed Web of Science ®Google Scholar
• Smith PA. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med. 2016;44(4):884–891. doi:10.1177/0363546515624678.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Yano K, Ikari K, Hiroshima R, Kawakami K, Koenuma N, Ishibashi M, Shirahata T, Momohara S. Platelet-rich plasma for the reduction of blood loss after total knee arthroplasty: a clinical trial. Eur J Orthop Surg Traumatol. 2016;26(8):901–905. doi:10.1007/s00590-016-1821-8.
   PubMedGoogle Scholar
• Pandey V, Bandi A, Madi S, Agarwal L, Acharya KK, Maddukuri S, Sambhaji C, Willems WJ. Does application of moderately concentrated platelet-rich plasma improve clinical and structural outcome after arthroscopic repair of medium-sized to large rotator cuff tear? A randomized controlled trial. J Shoulder Elbow Surg. 2016;25(8):1312–1322. doi:10.1016/j.jse.2016.01.036.
   PubMed Web of Science ®Google Scholar
• Flury M, Rickenbacher D, Schwyzer H-K, Jung C, Schneider MM, Stahnke K, Goldhahn J, Audigé L. Does pure platelet-rich plasma affect postoperative clinical outcomes after arthroscopic rotator cuff repair? A randomized controlled trial. Am J Sports Med. 2016;44(8):2136–2146. doi:10.1177/0363546516645518.
   PubMed Web of Science ®Google Scholar
• Seijas R, Cuscó X, Sallent A, Serra I, Ares O, Cugat R. Pain in donor site after BTB-ACL reconstruction with PRGF: a randomized trial. Arch Orthop Trauma Surg. 2016;136(6):829–835. doi:10.1007/s00402-016-2458-0.
   PubMed Web of Science ®Google Scholar
• Wesner M, Defreitas T, Bredy H, Pothier L, Qin Z, McKillop AB, Gross DP. A pilot study evaluating the effectiveness of platelet-rich plasma therapy for treating degenerative tendinopathies: a randomized control trial with synchronous observational cohort. PLoS One. 2016;11(2):e0147842. doi:10.1371/journal.pone.0147842.
   PubMed Web of Science ®Google Scholar
• Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, Nguyen JT, Solomon JL, Lutz GE. lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. Pm R. 2016;8(1):1–10; quiz 10 doi:10.1016/j.pmrj.2015.08.010.
   PubMedGoogle Scholar
• Chen YM, Hu FR, Huang JY, Shen EP, Tsai TY, Chen WL. The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty. Am J Ophthalmol. 2010;150(3):352–359 e352. doi:10.1016/j.ajo.2010.03.024.
   PubMed Web of Science ®Google Scholar
• Na KS, Kim MS. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J Ocul Pharmacol Ther. 2012;28(5):479–483. doi:10.1089/jop.2012.0002.
   PubMed Web of Science ®Google Scholar
• Pezzotta S, Del Fante C, Scudeller L, Cervio M, Antoniazzi ER, Perotti C. Autologous platelet lysate for treatment of refractory ocular GVHD. Bone Marrow Transplant. 2012;47(12):1558–1563. doi:10.1038/bmt.2012.64.
   PubMed Web of Science ®Google Scholar